144 related articles for article (PubMed ID: 7055802)
1. Fluoresceinated estrone binding by human and mouse breast cancer cells.
Fisher B; Gunduz N; Zheng S; Saffer EA
Cancer Res; 1982 Feb; 42(2):540-9. PubMed ID: 7055802
[No Abstract] [Full Text] [Related]
2. Adrenal dehydroepiandrosterone and human mammary cancer.
Adams JB; Archibald L; Clarke C
Cancer Res; 1978 Nov; 38(11 Pt 2):4036-40. PubMed ID: 151584
[No Abstract] [Full Text] [Related]
3. Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Correlation with conventional biochemical assays.
Curtin CT; Pertschuk LP; Mitchell V
Acta Cytol; 1982; 26(6):841-6. PubMed ID: 6961721
[TBL] [Abstract][Full Text] [Related]
4. An improved assay for nuclear estrogen receptor in experimental and human breast cancer.
Garola RE; McGuire WL
Cancer Res; 1977 Sep; 37(9):3333-7. PubMed ID: 884677
[TBL] [Abstract][Full Text] [Related]
5. Early stages in estrogen control of gene expression and its derangement in cancer.
Bresciani F; Nola E; Sica V; Puca GA
Fed Proc; 1973 Nov; 32(11):2126-32. PubMed ID: 4359599
[No Abstract] [Full Text] [Related]
6. [Estrogen receptor (ER) of breast cancer cells. II. Quantitative analysis of breast cancer cells bound with fluoresceinate-ER].
Zheng S
Zhonghua Zhong Liu Za Zhi; 1986 Mar; 8(2):96-9. PubMed ID: 3769750
[TBL] [Abstract][Full Text] [Related]
7. Effects of plasma estrogen sulfates in mammary cancer cells.
Vignon F; Terqui M; Westley B; Derocq D; Rochefort H
Endocrinology; 1980 Apr; 106(4):1079-86. PubMed ID: 6244140
[No Abstract] [Full Text] [Related]
8. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
Hansen ER; Brooks SC
Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
[No Abstract] [Full Text] [Related]
10. The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer.
Opolski A; Mazurkiewicz M; Wietrzyk J; Kleinrok Z; Radzikowski C
J Exp Clin Cancer Res; 2000 Sep; 19(3):383-90. PubMed ID: 11144533
[TBL] [Abstract][Full Text] [Related]
11. The status of estrogen receptor of breast cancer cell. Quantitative analysis of estrogen receptor status in fluoresceinated breast cancer cells.
Zheng S; Li JG; Fisher B
Chin Med J (Engl); 1985 Sep; 98(9):649-54. PubMed ID: 3938379
[No Abstract] [Full Text] [Related]
12. [Problems posed by the morphologic demonstration of estrogen receptors].
Mazabrey D; Jozan S; Marques B; David JF
Bull Assoc Anat (Nancy); 1986 Sep; 70(210):25-34. PubMed ID: 3327546
[TBL] [Abstract][Full Text] [Related]
13. Nuclear translocation and interactions of the estrogen receptor in uterus and mammary tumors.
Rochefort H; André J; Baskevitch PP; Kallos J; Vignon F; Westley B
J Steroid Biochem; 1980 Jan; 12():135-42. PubMed ID: 7421202
[No Abstract] [Full Text] [Related]
14. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
[TBL] [Abstract][Full Text] [Related]
15. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
Syne JS; Markaverich BM; Clark JH; Panko WB
Cancer Res; 1982 Nov; 42(11):4449-54. PubMed ID: 7127287
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of estrogen receptors in human breast cancer.
Olsnes S; Pihl A
Biomedicine; 1974 Nov; 20(6):377-83. PubMed ID: 4376029
[No Abstract] [Full Text] [Related]
17. Interrelation between tumor cell proliferation and 17-fluoresceinated estrone binding following primary tumor removal, radiation, cyclophosphamide, or tamoxifen.
Fisher B; Gunduz N; Saffer EA
Cancer Res; 1983 Nov; 43(11):5244-7. PubMed ID: 6616461
[TBL] [Abstract][Full Text] [Related]
18. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.
Pontiggia O; Rodriguez V; Fabris V; Raffo D; Bumaschny V; Fiszman G; de Kier Joffé EB; Simian M
Breast Cancer Res Treat; 2009 Jul; 116(2):247-55. PubMed ID: 18622696
[TBL] [Abstract][Full Text] [Related]
20. The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells.
Yde CW; Clausen MP; Bennetzen MV; Lykkesfeldt AE; Mouritsen OG; Guerra B
Anticancer Drugs; 2009 Sep; 20(8):723-35. PubMed ID: 19584708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
